Loading...
Loading...
Market Overview
MRNA closed at $40.48 on February 11, 2026, showing a minimal change of 0.01% from the previous close, continuing its downtrend with a 30-day return of -1.99%. The stock has traded between a low of $36.66 and a high of $45.50 over the past month, reflecting ongoing volatility. Upcoming clinical data and earnings reports may influence price action. Technical indicators show the 20-day moving average at 40.47, with the 50-day and 200-day averages not provided; the RSI is not specified. Nearest support is at $37.00 and resistance near $45.00. The trend remains downward with consolidation near current levels. For information only.
Last Updated 2/12/26

Sam Bourgi is an analyst, writer and financial market commentator featured in and cited by U.S. Congress, Department of Justice, Chicago Board Options Exchange, Barron's and Forbes. He covers stocks, bonds, mutual funds, ETFs, forex, Bitcoin, cryptocurrency, real estate and macroeconomics. He has written over 25,000 articles and over 40 whitepapers and e-books.